Similar Items: Incidence, Complications, and Quality of Life in Adults ≥ 60 Years Old With Laboratory‐Confirmed RSV Infections Attended in Primary Care and in Hospitals: A Study Over Three Seasons in Valladolid, Spain
- Characteristics and Risk Factors Associated With Hospitalization and Severe Disease in Patients Aged ≥ 60 Years With Human Metapneumovirus Infection Over Three Consecutive Seasons (2021–2024) in Valladolid, Spain. The VALLAVIRUS Study
- Correction to “Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024‐2025 Winter Season.”
- Country‐Level RSV‐Related Hospitalisation Rates Among Adults in High‐Income Countries From an Ensemble Model Based on Direct Viral Testing Incidence Data
- Reduction in Respiratory Syncytial Virus (RSV)‐Related Outpatient and Inpatient Cases Among Infants During the Initial 2024/2025 Season Following Nirsevimab Recommendation in Germany
- Impact of Respiratory Viral Codetections on RSV Disease Burden in Young Children in Primary Care
- The Role of CC10 Combined With CysLTs in Predicting Subsequent Wheezing in RSV-Infected Bronchiolitis